Given miR-708-5p’s ability to enhance p53 and CHOP protein expression, we examined the molecular and phenotypic consequences of combinatory miR-708-5p and chemotherapy treatments in lung cancer cells. This evidence concerns the gene DDIT3 and lung cancer.